A California trader conducted a pump-and-dump scheme for biotech company, the agency said.
A massive wave of corporate distress is pitting beleaguered companies against their lenders.
Most of the growth in earnings and employment over the past decade has been an illusion, Jeffrey Gundlach argued.
The two hot topics are at the top of the agenda for the regulator's board of governors meeting this week.
The coronavirus-induced spending splurge weighs heavily on the national debt.
High-yield munis have returned 7.8% since April 1.
As expected, the Fed said it will keep rates low and continue quantitative easing in the near term.
Mnuchin spoke highly of the effectiveness of current stimulus and called for more.
The global stock market’s capitalization has climbed by roughly $22 trillion from the March low.
Investors are getting adventurous as they bet on a revival in global economic activity and friendly Fed policies.
Covid-19 will result in permanent market changes, according to Hartford Funds' Simon Webber.
The company said it expects to report an adjusted loss of 55 to 70 cents a share.
The timing is tight, considering medicine’s quickest previous vaccine took four years to be developed.
The infection won’t “burn itself out with mere public health measures,” he said.
Hurricanes have become more violent and more expensive because of climate change.
The CLO market could rev up as the pandemic purges the market of its excesses.
Covid-19 cases have increased in some reopened states, remained stable in others.
Companies see suspensions as a way to boost cash flow and avoid or limit job cuts.
In some respects, it’s almost as if the pandemic never happened.
America’s food suppliers have seen some of the worst Covid-19 outbreaks of any industry outside health care.